[
  {
    "ts": "2026-01-09T01:38:10+00:00",
    "headline": "Dow Jones Futures: Jobs Data, Trump Tariffs Ruling Loom After Small Caps Lead Split Market",
    "summary": "Small caps hit a new high Thursday as techs faltered. The December jobs report a possible Trump tariffs ruling loom Friday.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-small-caps-jobs-data-trump-tariffs-ruling/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "2a3d656e-215b-3c5a-8913-f46b10c1962e",
      "content": {
        "id": "2a3d656e-215b-3c5a-8913-f46b10c1962e",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Jobs Data, Trump Tariffs Ruling Loom After Small Caps Lead Split Market",
        "description": "",
        "summary": "Small caps hit a new high Thursday as techs faltered. The December jobs report a possible Trump tariffs ruling loom Friday.",
        "pubDate": "2026-01-09T01:38:10Z",
        "displayTime": "2026-01-09T01:38:10Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/2a3d656e-215b-3c5a-8913-f46b10c1962e/dow-jones-futures-jobs-data-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/64ef26e69822a4e4837c82dd3425fad5",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a7cU.xPWSHpzasiZQqNSKQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/64ef26e69822a4e4837c82dd3425fad5.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vd.TiGl0aqSn9so9Pgd.5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/64ef26e69822a4e4837c82dd3425fad5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-small-caps-jobs-data-trump-tariffs-ruling/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "VLO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T03:25:14+00:00",
    "headline": "Dow Jones Futures: Jobs Data, Trump Tariffs Ruling Loom After Small Caps Lead",
    "summary": "Small caps hit a new high Thursday as techs faltered. The December jobs report a possible Trump tariffs ruling loom Friday.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-small-caps-jobs-data-trump-tariffs-ruling/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "2a3d656e-215b-3c5a-8913-f46b10c1962e",
      "content": {
        "id": "2a3d656e-215b-3c5a-8913-f46b10c1962e",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Jobs Data, Trump Tariffs Ruling Loom After Small Caps Lead",
        "description": "",
        "summary": "Small caps hit a new high Thursday as techs faltered. The December jobs report a possible Trump tariffs ruling loom Friday.",
        "pubDate": "2026-01-09T03:25:14Z",
        "displayTime": "2026-01-09T03:25:14Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/2a3d656e-215b-3c5a-8913-f46b10c1962e/dow-jones-futures-jobs-data-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/64ef26e69822a4e4837c82dd3425fad5",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a7cU.xPWSHpzasiZQqNSKQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/64ef26e69822a4e4837c82dd3425fad5.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vd.TiGl0aqSn9so9Pgd.5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/64ef26e69822a4e4837c82dd3425fad5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-small-caps-jobs-data-trump-tariffs-ruling/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "CRS"
            },
            {
              "symbol": "TJX"
            },
            {
              "symbol": "SN"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "VLO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T08:13:08+00:00",
    "headline": "Is AbbVie (ABBV) Still Attractive After Strong 1-Year And 5-Year Share Price Gains?",
    "summary": "If you are wondering whether AbbVie at around US$224 per share still offers value, or if most of the opportunity is already priced in, this article is for you. The stock is roughly flat over the last month with a 0.5% return, but that sits alongside a 30.0% return over 1 year and 141.2% over 5 years, which can change how investors think about both risk and potential reward. Recent headlines have focused on AbbVie’s position as a major US pharmaceuticals and biotech player and how its...",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-still-attractive-strong-081308582.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "a2aed4d0-706e-3b3f-aa45-ea46ae14f183",
      "content": {
        "id": "a2aed4d0-706e-3b3f-aa45-ea46ae14f183",
        "contentType": "STORY",
        "title": "Is AbbVie (ABBV) Still Attractive After Strong 1-Year And 5-Year Share Price Gains?",
        "description": "",
        "summary": "If you are wondering whether AbbVie at around US$224 per share still offers value, or if most of the opportunity is already priced in, this article is for you. The stock is roughly flat over the last month with a 0.5% return, but that sits alongside a 30.0% return over 1 year and 141.2% over 5 years, which can change how investors think about both risk and potential reward. Recent headlines have focused on AbbVie’s position as a major US pharmaceuticals and biotech player and how its...",
        "pubDate": "2026-01-09T08:13:08Z",
        "displayTime": "2026-01-09T08:13:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-still-attractive-strong-081308582.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-still-attractive-strong-081308582.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T10:54:00+00:00",
    "headline": "Revolution Medicines Stock Soars. Takeover Buzz Grows, Another Suitor Emerges.",
    "summary": "Revolution Medicines stock was soaring again early Friday after a report that Merck is in talks to buy the cancer-drug biotech for up to $32 billion.",
    "url": "https://www.barrons.com/articles/revolution-medicines-stock-takeover-merck-abbvie-78d054a3?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ef8334d9-28aa-3ad8-bd50-47a1df3709c8",
      "content": {
        "id": "ef8334d9-28aa-3ad8-bd50-47a1df3709c8",
        "contentType": "STORY",
        "title": "Revolution Medicines Stock Soars. Takeover Buzz Grows, Another Suitor Emerges.",
        "description": "",
        "summary": "Revolution Medicines stock was soaring again early Friday after a report that Merck is in talks to buy the cancer-drug biotech for up to $32 billion.",
        "pubDate": "2026-01-09T10:54:00Z",
        "displayTime": "2026-01-09T10:54:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ef8334d9-28aa-3ad8-bd50-47a1df3709c8/revolution-medicines-stock.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/6d7c7e6deca332edc057f66f7d34ab81",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tm7_i1CbepBPlo4fMe6Zyw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/6d7c7e6deca332edc057f66f7d34ab81.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Zligtyq_hRNskgB8cTQyrg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/6d7c7e6deca332edc057f66f7d34ab81.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/revolution-medicines-stock-takeover-merck-abbvie-78d054a3?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T12:28:51+00:00",
    "headline": "HSBC lists 11 potential U.S. outperformers heading into earnings",
    "summary": "Investing.com -- HSBC has identified 11 U.S. stocks that could outperform as the fourth-quarter earnings season begins, highlighting companies with strong competitive positions, improving fundamentals and exposure to long-term themes.",
    "url": "https://finance.yahoo.com/news/hsbc-lists-11-potential-u-122851129.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "45e59105-3e9d-3905-9d79-58812348bf8b",
      "content": {
        "id": "45e59105-3e9d-3905-9d79-58812348bf8b",
        "contentType": "STORY",
        "title": "HSBC lists 11 potential U.S. outperformers heading into earnings",
        "description": "",
        "summary": "Investing.com -- HSBC has identified 11 U.S. stocks that could outperform as the fourth-quarter earnings season begins, highlighting companies with strong competitive positions, improving fundamentals and exposure to long-term themes.",
        "pubDate": "2026-01-09T12:28:51Z",
        "displayTime": "2026-01-09T12:28:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hsbc-lists-11-potential-u-122851129.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hsbc-lists-11-potential-u-122851129.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSBC"
            },
            {
              "symbol": "TMO"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T12:44:00+00:00",
    "headline": "Here's What We Expect From AbbVie's Immunology Segment in Q4",
    "summary": "ABBV's Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humira's past loss of exclusivity.",
    "url": "https://finance.yahoo.com/news/heres-expect-abbvies-immunology-segment-124400845.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "56543896-1532-3429-ae94-e3a17404ce99",
      "content": {
        "id": "56543896-1532-3429-ae94-e3a17404ce99",
        "contentType": "STORY",
        "title": "Here's What We Expect From AbbVie's Immunology Segment in Q4",
        "description": "",
        "summary": "ABBV's Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humira's past loss of exclusivity.",
        "pubDate": "2026-01-09T12:44:00Z",
        "displayTime": "2026-01-09T12:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-expect-abbvies-immunology-segment-124400845.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-expect-abbvies-immunology-segment-124400845.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]